Medical Journal March 11, 2023

Published Date: 17 Mar 2023

Today's top news includes: New study finds millions of people around the world are having heart attacks after being tested for COVID-19 vaccines...

Read Full News

Latest News

Practice-Changing Ovarian Cancer Updates From SGO 2026

Dr Bradley Corr reviews data on the NRG-GY019 and ROSELLA trials, and discusses their clinical impact on ovarian cancer care.

Episode 5: Secondary Hypertension and Pregnancy

Drs Marwah Abdalla and Kara K. Hoppe discuss hypertension and pregnancy, including preconception counseling, postpartum management, and long-term cardiovascular health.

No Need to Worry About GLP-1-Induced Muscle Loss

Recent headlines have alarmingly stated dramatic muscle loss for patients on GLP-1s. Yoni Freedhoff, MD, explains why this is a manufactured controversy.

Woman Develops Systemic Sarcoidosis After Eyebrow Tattoo

A 46-year-old woman developed disseminated sarcoidosis after an eyebrow tattoo, with lesions spreading to distant, nontattooed skin and bilateral hilar nodes.

AF Pulsed Field Ablation Disappoints in Setup for Success

The AVANT GUARD trial design stacked the odds in favor of PFA over antiarrhythmic drugs. Yet, the results are unconvincing to this electrophysiologist. Maybe not all PFA systems are created equal.

Apr 24 2026 This Week in Cardiology

PCSK9 inhibitors in high-risk diabetes without ASCVD, the CAAN-AF trial, conduction system pacing vs biventricular pacing, PFA and stroke, and therapeutic fashion infects expert consensus are the topics John Mandrola, MD, discusses in this week's podcast.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Latest News

Dr Bradley Corr reviews data on the NRG-GY019 and ROSELLA trials, and discusses their clinical impact on ovarian cancer care.

Drs Marwah Abdalla and Kara K. Hoppe discuss hypertension and pregnancy, including preconception counseling, postpartum management, and long-term cardiovascular health.

Recent headlines have alarmingly stated dramatic muscle loss for patients on GLP-1s. Yoni Freedhoff, MD, explains why this is a manufactured controversy.

A 46-year-old woman developed disseminated sarcoidosis after an eyebrow tattoo, with lesions spreading to distant, nontattooed skin and bilateral hilar nodes.

The AVANT GUARD trial design stacked the odds in favor of PFA over antiarrhythmic drugs. Yet, the results are unconvincing to this electrophysiologist. Maybe not all PFA systems are created equal.

PCSK9 inhibitors in high-risk diabetes without ASCVD, the CAAN-AF trial, conduction system pacing vs biventricular pacing, PFA and stroke, and therapeutic fashion infects expert consensus are the topics John Mandrola, MD, discusses in this week's podcast.

News All Time

BCR in Prostate Cancer: What It Means and What Comes Next

Biochemical recurrence is one of the most challenging scenarios in prostate cancer care. Dr David Einstein explores how clinicians interpret rising PSA levels and highlights management strategies.

Mandrola’s Top 4 Trials from ACC 2026

Trials on Impella in high-risk PCI, percutaneous left atrial appendage closure, CTO-PCI, and spironolactone in HFpEF are Mandrola’s most anticipated at the upcoming 2026 ACC meeting in New Orleans.

US FDA Extends Review Of Lantheus' Diagnostic Imaging Kit by Three Months

Lantheus Holdings said on Tuesday that the U.S. health regulator has extended its review of the ⁠company's diagnostic imaging kit by three months as it needs more time to...

Can AI Restore the Power of the Stethoscope?

New trials show AI can identify serious cardiac disease from heart sounds alone, yet technology only changes outcomes when clinicians trust it and use it consistently.

Erectile Dysfunction in Young Man Reveals Prolactinoma

A laboratory abnormality during the evaluation of erectile dysfunction in a young man leads clinicians to identify hyperprolactinemia and a pituitary tumor on MRI.

Incidentalomas and Anxiety in Whole-Body Screening

Dr Bishal Gyawali discusses the rising trend of whole-body scans for cancer screening and how they can cause more harm than good.

Enhancing Shared Decision-Making in Early Breast Cancer

Experts discuss communication approaches that enhance shared decision-making for patients with early breast cancer, spanning surgery, adjuvant therapy, and survivorship.

Bannwarth Syndrome in a Woman With Early Breast Cancer

The case emphasizes Bannwarth syndrome as a rare but treatable cause of neurologic deterioration in an older woman receiving surgical cancer care.

Can Large Language Models Simplify Radiology Reports?

A meta-analysis suggests that large language model-simplified radiology reports improve patient understanding and readability while preserving high accuracy and completeness.

NPH: What You Learned in Med School Is Wrong

Neurologists Indu Subramanian and Alfonso Fasano discuss normal pressure hydrocephalus and why some of the classic dogma about this condition is wrong.

Medicine Will Turn Cellular Age Backward by 2050: Barzilai

Aging may not be permanent. Nir Barzilai explains how human cells reset to zero and why partial rejuvenation could be possible within decades.

Promoting Whole-Body Imaging: Not There Yet

Ethicist Art Caplan discusses marketing promotions for expensive whole-body imaging.

Adding to the Toolbox: Thyroid Artery Embolization

Drs Kaniksha Desai and Juan Camacho discuss thyroid artery embolization.

The Time Burden of Cancer Treatment

Dr Kathy Miller discusses a recent study quantifying the hidden time burden of cancer care and its impact on clinic operations and patient experience.

ASCO GI: Updates in Pancreatic, Gastric, CRC

Dr Emil Lou highlights practice-changing updates from ASCO GI, including new immunotherapy, targeted therapy, and circulating tumor DNA advances across gastrointestinal cancers.

New material may outperform current agents used in medical imaging

Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic to patients and more environmentally ...

Recommended News For You

Prior authorizations draining time, energy from many cancer patients

A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

Regular physical activity before cancer diagnosis may lower progression and death risks

combating racial discrimination in next-generation breast cancer screening.

A new theranostic drug targets different cancer types.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

Recommended Articles For You

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights 

Unmasking the Subtle Symptoms of Colon Cancer 

Survival Rates in Cancer: Focus on Acute Myeloid Leukemia and Other Malignancies 

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Number of cancer survivors in the US reaches 18.6 million—projected to exceed 22 million by 2035

2.

When Should Immunocompromised Individuals Receive a COVID Booster?

3.

Novel biomarker has potential for predicting and treating skin cancer metastasis

4.

Taking Charge of Your Cancer Journey.

5.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

1.

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection

2.

The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025

3.

Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy

4.

Cowden Syndrome and Cancer: Understanding the Risk Factors 

5.

Cemiplimab: A Revolutionary Drug For Treating Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

2.

Efficient Management of First line ALK-rearranged NSCLC

3.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

5.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot